Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Effect of Fluconazole on SHR2554 in Healthy Subjects
NCT05661591Phase 1Completed
- Sponsor
- Hengrui
- Start
- Feb 2023
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of zeprumetostat in lymphoma, sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time 0 to time t and 1 more. Started Feb 2023; status: completed.
02
Drugs
zeprumetostat
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT05661591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05661591.